| __timestamp | ACADIA Pharmaceuticals Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 241751000 |
| Thursday, January 1, 2015 | 76369000 | 322292000 |
| Friday, January 1, 2016 | 4406000 | 344320000 |
| Sunday, January 1, 2017 | 13060000 | 374644000 |
| Monday, January 1, 2018 | 18330000 | 1820000 |
| Tuesday, January 1, 2019 | 19598000 | 4000000 |
| Wednesday, January 1, 2020 | 20550000 | 12000000 |
| Friday, January 1, 2021 | 19141000 | 11000000 |
| Saturday, January 1, 2022 | 10166000 | 14000000 |
| Sunday, January 1, 2023 | 45731000 | 9133000 |
| Monday, January 1, 2024 | 11215000 |
Unleashing insights
In the competitive world of pharmaceuticals, cost efficiency is a critical factor for success. This analysis compares the cost of revenue efficiency between Ionis Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc. from 2014 to 2023. Over this period, Ionis Pharmaceuticals consistently demonstrated a higher cost of revenue, peaking in 2017 with a staggering 374 million, while ACADIA's highest was in 2015 at 76 million. However, ACADIA showed a remarkable improvement in cost efficiency, reducing its cost of revenue by approximately 40% from 2015 to 2022. In contrast, Ionis experienced a significant drop in 2018, with costs plummeting by over 99% compared to the previous year. This data highlights the dynamic nature of the pharmaceutical industry, where strategic financial management can lead to substantial cost savings and improved profitability.
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs ACADIA Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Zoetis Inc. vs ACADIA Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: Incyte Corporation vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Viatris Inc. vs ACADIA Pharmaceuticals Inc.
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Ionis Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: Ionis Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Cost of Revenue Trends: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Cost of Revenue: Key Insights for Amneal Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs HUTCHMED (China) Limited